Multicenter Epidemiologic Study of Coronavirus Disease–Associated Mucormycosis, India
Supporting Files
Public Domain
-
Sep 2021
-
File Language:
English
Details
-
Alternative Title:Emerg Infect Dis
-
Personal Author:Patel, Atul ; Agarwal, Ritesh ; Rudramurthy, Shivaprakash M. ; Shevkani, Manoj ; Xess, Immaculata ; Sharma, Ratna ; Savio, Jayanthi ; Sethuraman, Nandini ; Madan, Surabhi ; Shastri, Prakash ; Thangaraju, Deepak ; Marak, Rungmei ; Tadepalli, Karuna ; Savaj, Pratik ; Sunavala, Ayesha ; Gupta, Neha ; Singhal, Tanu ; Muthu, Valliappan ; Chakrabarti, Arunaloke
-
Corporate Authors:
-
Description:During September-December 2020, we conducted a multicenter retrospective study across India to evaluate epidemiology and outcomes among cases of coronavirus disease (COVID-19)-associated mucormycosis (CAM). Among 287 mucormycosis patients, 187 (65.2%) had CAM; CAM prevalence was 0.27% among hospitalized COVID-19 patients. We noted a 2.1-fold rise in mucormycosis during the study period compared with September-December 2019. Uncontrolled diabetes mellitus was the most common underlying disease among CAM and non-CAM patients. COVID-19 was the only underlying disease in 32.6% of CAM patients. COVID-19-related hypoxemia and improper glucocorticoid use independently were associated with CAM. The mucormycosis case-fatality rate at 12 weeks was 45.7% but was similar for CAM and non-CAM patients. Age, rhino-orbital-cerebral involvement, and intensive care unit admission were associated with increased mortality rates; sequential antifungal drug treatment improved mucormycosis survival. The COVID-19 pandemic has led to increases in mucormycosis in India, partly from inappropriate glucocorticoid use.
-
Subjects:
-
Source:Emerg Infect Dis. 27(9):2349-2359
-
Pubmed ID:34087089
-
Pubmed Central ID:PMC8386807
-
Document Type:
-
Place as Subject:
-
Location:
-
Volume:27
-
Issue:9
-
Collection(s):
-
Main Document Checksum:urn:sha256:549686b7565be4dd448f8254a50c7f4bac2f323e307a69b46144ae508023f31a
-
Download URL:
-
File Type:
Supporting Files
File Language:
English
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like
COLLECTION
Emerging Infectious Diseases